"MADE IN ITALY" AND "MADE IN CHINA". EMPIRICAL ANALYSIS AND INDUSTRIAL POLICY IMPLICATIONS

quality, sectoral specialisation, international trade, price differentials

Gender in endocrine diseases: role of sex gonadal hormones

Gender- and sex- related differences represent a new frontier towards patient-tailored medicine, taking into account that theoretically every medical specialty can be influenced by both of them. Sex hormones define the differences between males and females, and the different endocrine environment promoted by estrogens, progesterone, testosterone, and their precursors might influence both human physiology and pathophysiology. With the term Gender we refer, instead, to behaviors, roles, expectations, and activities carried out by the individual in society. In other words, “gender” refers to a sociocultural sphere of the individual, whereas “sex” only defines the biological sex. In the last decade, increasing attention has been paid to understand the influence that gender can have on both the human physiology and pathogenesis of diseases. Even the clinical response to therapy may be influenced by sex hormones and gender, but further research is needed to investigate and clarify how they can affect the human pathophysiology. The path to a tailored medicine in which every patient is able to receive early diagnosis, risk assessments, and optimal treatments cannot exclude the importance of gender. In this review, we have focused our attention on the involvement of sex hormones and gender on different endocrine diseases

Effects of Head Formation and Heat Treatment on the Mechanical Properties of Connecting Rod Bolts

Oliver Racing Parts (ORP; Charlevoix, Michigan) is looking to optimize their manufacturing process for high-strength connecting rod bolts. A high yield strength is desired for the bolts because deformation would result in catastrophic engine failure. The bolts were made of H11, a chromium hot-work tool steel; and MLX17, a precipitation hardenable stainless steel. Tensile testing was performed to determine the tensile and yield strengths of the bolts. Fracture surfaces were imaged via scanning electron microscopy to characterize the failure modes. To observe the effects of bolt heading on microstructure and bolt strength, two batches of MLX17 were prepared; one batch being headed then aged (Group A); the other batch being headed, solution annealed, and then aged (Group B). These bolts were compared to H11 bolts to determine their viability for use, with the results being in the order of highest to lowest yield strength: H11 (272 ksi), MLX17 Treatment B (250 ksi), and MLX17 Treatment A (235 ksi). In the order of highest to lowest tensile strength: H11 (300 ksi), MLX17 Group B (255 ksi), MLX17 Group A (238 ksi). It is suggested that the bolt heading process is causing some overaging in the MLX17 samples, shown by the increase in strength when strain and aging from the heading process are undone through heat treatment. H11 bolts were the strongest tested. Recommendations are to not replace H11 bolts with MLX17 due to a decrease in strength

Tafassasset: The Saga Continues

In this study, we compare data for two separate Tafassasset stones and supply new oxygen isotope data for our sample. We include a discussion of the debate surrounding the classification of Tafassasset and offer a hypothesis for its origin based upon new information

Endocrine disrupting chemicals: Effects on endocrine glands

In recent years, endocrine disrupting chemicals have gained interest in human physiopathology and more and more studies aimed to explain how these chemicals compounds affect endocrine system. In human populations, the majority of the studies point toward an association between exposure to endocrine disrupting chemicals and the disorders affecting endocrine axis. A great number of endocrine disrupting chemicals seem to be able to interfere with the physiology of hypothalamus-pituitary-gonadal axis; however, every endocrine axis may be a target for each EDCs and their action is not limited to a single axis or organ. Several compounds may also have a negative impact on energy metabolic homeostasis altering adipose tissue and promoting obesity, metabolic syndrome, and diabetes. Different mechanism have been proposed to explain these associations but their complexity together with the degree of occupational or environmental exposure, the low standardization of the studies, and the presence of confounding factors have prevented to establish causal relationship between the endocrine disorders and exposure to specific toxicants so far. This manuscript aims to review the state of art of scientific literature regarding the effects of endocrine-disrupting chemicals (EDCs) on endocrine system

Specific and non-specific biomarkers in neuroendocrine gastroenteropancreatic tumors

The diagnosis of neuroendocrine tumors (NETs) is a challenging task: Symptoms are rarely specific, and clinical manifestations are often evident only when metastases are already present. However, several bioactive substances secreted by NETs can be included for diagnostic, prognostic, and predictive purposes. Expression of these substances differs between different NETs according to the tumor hormone production. Gastroenteropancreatic (GEP) NETs originate from the diffuse neuroendocrine system of the gastrointestinal tract and pancreatic islets cells: These tumors may produce many non-specific and specific substances, such as chromogranin A, insulin, gastrin, glucagon, and serotonin, which shape the clinical manifestations of the NETs. To provide an up-to-date reference concerning the different biomarkers, as well as their main limitations, we reviewed and summarized existing literature

Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC/PTC): An Italian multicenter study

Background: The concomitant presence of papillary thyroid cancer (PTC) and medullary TC (MTC) is rare. In this multicentric study, we documented the epidemiological characteristics, disease conditions and clinical outcome of patients with simultaneous MTC/PTC. Methods: We collected data of patients with concomitant MTC/PTC at 14 Italian referral centers. Results: In total, 183 patients were enrolled. Diagnosis was mostly based on cytological examination (n = 58, 32%). At diagnosis, in the majority of cases, both PTC (n = 142, 78%) and MTC (n = 100, 54%) were at stage I. However, more cases of stage II\u2013IV were reported with MTC (stage IV: n = 27, 15%) compared with PTC (n = 9, 5%). Information on survival was available for 165 patients: 109 patients (66%) were disease-free for both PTC and MTC at the last follow-up. Six patients died from MTC. Median time to progression was 123 months (95% confidence interval (CI): 89.3\u2013156.7 months). Overall, 45% of patients were disease-free after >10 years from diagnosis (125 months); this figure was 72.5% for PTC and 51.1% for MTC. Conclusions: When MTC and PTC are concurrent, the priority should be given to the management of MTC since this entity appears associated with the most severe impact on prognosis